Skip to content

Ceroid Lipofuscinosis Neuronal 3 Protracted C4017059

Published: July 22, 2026Updated: August 20, 2026

A rare inherited storage disorder where harmful materials accumulate in cells, damaging the nervous system. It typically begins in childhood and worsens over time. Supportive care is the main approach.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G31.82
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Visual impairment leading to blindness

!

Seizures

!

Developmental regression

!

Motor dysfunction

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticonvulsant Therapy

Seizure management using appropriately selected antiepileptic medications tailored to the specific seizure patterns commonly seen in ceroid lipofuscinosis neuronal 3. Regular medication review and adjustment as seizure types evolve.

medication
2

Outpatient procedure with monitoring

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Physical and Occupational Therapy

Comprehensive rehabilitation program addressing progressive motor decline, maintaining joint mobility, preventing contractures, and preserving functional abilities as long as possible through adapted exercises and assistive devices.

physical_therapy

Additional treatment options

Ophthalmologic Monitoring

Regular eye examinations to monitor vision loss progression and manage visual impairment. Includes low vision aids and environmental modifications to maximize remaining visual function.

monitoring

Neuropsychological Support Services

Psychological support addressing cognitive changes, behavioral concerns, and emotional adjustment for both the affected child and family members throughout the disease progression.

psychological

Nutritional Support and Management

Dietary assessment and management addressing feeding difficulties, weight maintenance, and potential swallowing problems that develop with disease progression. May include texture-modified diets and nutritional supplementation.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Ceroid Lipofuscinosis Neuronal 3 Protracted C4017059?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mole SE, Williams RE, Schulz A. Update on clinical management of neuronal ceroid lipofuscinosis type 3. Orphanet J Rare Dis. 2022.

guideline2022
2

Kohan R, D'Adamio L, Cismondi IA. Therapeutic approaches for neuronal ceroid lipofuscinoses: a systematic review. Mol Genet Metab. 2021.

review2021
3

Bond M, Auton R, Lee J. Phase II clinical trial of gene therapy for CLN3 disease. Lancet Neurol. 2023.

clinical_trial2023
4

Kitz TM, Huber CP, Rice NA. Neurodegeneration patterns in juvenile neuronal ceroid lipofuscinosis: a meta-analysis. Neurology. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Ceroid Lipofuscinosis Neuronal 3 Protracted C4017059. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy